Journal of Atherosclerosis and Thrombosis
Online ISSN : 1880-3873
Print ISSN : 1340-3478
Reviews
Regulation of CX3CL1/Fractalkine Expression in Endothelial Cells
Tadaatsu ImaizumiHidemi YoshidaKei Satoh
Author information
JOURNALS FREE ACCESS

2004 Volume 11 Issue 1 Pages 15-21

Details
Abstract

CX3CL1/fractalkine is a chemokine with a unique CX3C motif. Fractalkine is synthesized in endothelial cells as a membrane protein, and the N-terminal domain containing a CX3C motif is cleaved and secreted. CX3CR1, the specific receptor for fractalkine, is expressed in monocytes and lymphocytes. Membrane-bound fractalkine works as an adhesion molecule for these leukocytes and the secreted form as a chemotactic factor. Fractalkine is produced by endothelial cells stimulated with tumor necrosis factor-α, interleukin-1 (IL-1), lipopolysaccharide and interferon-γ. Expression of fractalkine in endothelial cells is inhibited by the soluble form of IL-6 receptor-α, 15-deoxy-Δ12,14-prostaglandin J2, and hypoxia. The expression of fractalkine is tightly regulated and fractalkine plays an important role in the interaction between leukocytes and endothelial cells.

Information related to the author
Previous article Next article
feedback
Top